A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation
about
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trialEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trialsThe next step in translational research: lessons learned from the first preclinical randomized controlled trial.Regulatory T Cells in Post-stroke Immune Homeostasis.Concise Review: Increasing the Validity of Cerebrovascular Disease Models and Experimental Methods for Translational Stem Cell Research.Standardized mean differences cause funnel plot distortion in publication bias assessments.NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage.NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage.Reliability of infarct volumetry: Its relevance and the improvement by a software-assisted approach.A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection.In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation.
P2860
Q28587757-343B6893-07E9-4E6E-A31A-67F5E9621400Q33761211-6F918839-198E-4D87-8914-573B05D3ADE6Q36275582-8AC0B401-6005-4996-BAFB-559FE7426595Q38770603-0C1AA4C6-0F57-40E3-8B7E-C436C3E56023Q38794156-C077C26E-C915-4829-9FA0-9639BF1CB15CQ39138693-9689028F-5ED0-42D3-86D0-A2233B1DE67BQ40051493-69BCBD34-A827-4FDB-88CA-F994DD0A40A2Q41022884-C6210946-4FE7-4805-BB36-AA3F18F339F2Q42503323-10557C36-2475-44B8-87AD-71232095926AQ48409685-2A6DAFF9-0EFA-4459-9CEA-2327698F6E50Q49718583-51624519-ABA7-4F05-92AD-E729E3FDD830Q55380020-E3ECF453-D8B0-477A-B89B-C4D2D077973C
P2860
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A combined pre-clinical meta-a ...... therapeutic target validation
@ast
A combined pre-clinical meta-a ...... therapeutic target validation
@en
A combined pre-clinical meta-a ...... therapeutic target validation
@en-gb
A combined pre-clinical meta-a ...... therapeutic target validation
@nl
type
label
A combined pre-clinical meta-a ...... therapeutic target validation
@ast
A combined pre-clinical meta-a ...... therapeutic target validation
@en
A combined pre-clinical meta-a ...... therapeutic target validation
@en-gb
A combined pre-clinical meta-a ...... therapeutic target validation
@nl
prefLabel
A combined pre-clinical meta-a ...... therapeutic target validation
@ast
A combined pre-clinical meta-a ...... therapeutic target validation
@en
A combined pre-clinical meta-a ...... therapeutic target validation
@en-gb
A combined pre-clinical meta-a ...... therapeutic target validation
@nl
P2093
P2860
P50
P356
P1433
P1476
A combined pre-clinical meta-a ...... therapeutic target validation
@en
P2093
Friederike Langhauser
Harald H H W Schmidt
Merel Ritskes-Hoitinga
Pamela W M Kleikers
Sarah S J Rewell
P2860
P2888
P356
10.1038/SREP13428
P407
P577
2015-01-01T00:00:00Z
P5875
P6179
1049598271